CD4 and cancer: Additionally, platelet-thrombocyte aggregates (PTAs) are associated with an increased risk of thrombosis, with cancer patients exhibiting significantly higher percentages of PTAs among CD4+ and CD8+ T lymphocyte populations compared to healthy individuals (195).